规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | GPR120 Agonist 3 exhibits complete selectivity for Gpr120 (logEC50=-7.62) with negligible activity towards Gpr40. It induces a concentration-dependent increase in IP3 production in human and mouse Gpr120-expressing cells. GPR120 Agonist 3 elicits a concentration-dependent response in these cells, recruiting β-arrestin-2 with an EC50 of approximately 0.35 μM. It also potently and equivalently inhibits LPS-induced phosphorylation of Tak1, Ikkβ, and Jnk, and prevents the degradation of IκB[1]. |
Animal study | GPR120 Agonist 3 improves insulin sensitivity by increasing the rate of glucose infusion and enhancing the rate of glucose disposal stimulated by insulin, and it significantly increases the ability of insulin to inhibit hepatic glucose production only in WT mice. Treatment with GPR120 Agonist 3 has beneficial effects on hepatic lipid metabolism, reducing hepatic steatosis, lowering hepatic triglycerides and DAG levels, while also decreasing the content of saturated free fatty acids[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.46mL 0.49mL 0.25mL |
12.32mL 2.46mL 1.23mL |
24.64mL 4.93mL 2.46mL |
CAS号 | 1599477-75-4 |
分子式 | C19H23ClF3NO3 |
分子量 | 405.839 |
别名 | GPR120 Compound A;GPR120 cpdA;MDK77754 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 50 mg/mL(123.2 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |